dc.contributor.author | YAZICI, H | |
dc.contributor.author | BARNES, CG | |
dc.date.accessioned | 2021-03-03T14:24:58Z | |
dc.date.available | 2021-03-03T14:24:58Z | |
dc.date.issued | 1991 | |
dc.identifier.citation | YAZICI H., BARNES C., "PRACTICAL TREATMENT RECOMMENDATIONS FOR PHARMACOTHERAPY OF BEHCETS-SYNDROME", DRUGS, cilt.42, sa.5, ss.796-804, 1991 | |
dc.identifier.issn | 0012-6667 | |
dc.identifier.other | av_395e7a16-ee93-4dff-a278-506534190111 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/42605 | |
dc.identifier.uri | https://doi.org/10.2165/00003495-199142050-00006 | |
dc.description.abstract | Behcet's syndrome is a disease of unknown aetiology classified among the vasculitides. It runs a course of exacerbations and remissions which gradually abate with time. Eye disease, the most frequent cause of serious morbidity, may lead to blindness in 20% of those affected. The syndrome may occasionally be fatal due to vasculitis leading to arterial occlusion, ruptured arterial aneurysms or pulmonary vasculitis, or involvement of the central nervous system. | |
dc.language.iso | eng | |
dc.subject | Farmasötik Toksikoloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Eczacılık | |
dc.subject | Meslek Bilimleri | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TOKSİKOLOJİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.title | PRACTICAL TREATMENT RECOMMENDATIONS FOR PHARMACOTHERAPY OF BEHCETS-SYNDROME | |
dc.type | Makale | |
dc.relation.journal | DRUGS | |
dc.contributor.department | , , | |
dc.identifier.volume | 42 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 796 | |
dc.identifier.endpage | 804 | |
dc.contributor.firstauthorID | 113136 | |